The Apolipoprotein C pipeline drugs market research report outlays comprehensive information on the Apolipoprotein C targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the Apolipoprotein C pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Metabolic Disorders, Cardiovascular, and Genetic Disorders which include the indications Hypertriglyceridemia, Familial Chylomicronemia (Type I Hyperlipoproteinemia), Hypertension, Atherosclerosis, and Hemochromatosis. It also reviews key players involved in Apolipoprotein C targeted therapeutics development with respective active and dormant or discontinued products.
The Apolipoprotein C pipeline targets constitutes close to 13 molecules. Out of which, approximately 12 molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Pre-Registration, Filing rejected/ Withdrawn, Phase III, Phase II, Phase I, Preclinical, and Discovery stages are 1, 1, 1, 1, 2, 5, and 1 respectively. Similarly, the universities portfolio in Preclinical comprises 1 molecule.
Apolipoprotein C overview
Apolipoprotein C (apoC) is a group of proteins that are associated with lipoprotein particles, which are involved in the transportation of lipids in the body, including cholesterol and triglycerides. Apolipoprotein C is found on the surface of very low-density lipoproteins (VLDLs) and high-density lipoproteins (HDLs) and has a role in lipid metabolism.
For a complete picture of Apolipoprotein C’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.